Center-Authored Papers

Filters: Keyword is Aromatase Inhibitors  [Clear All Filters]
G
Goss PE, Ingle JN, Alés-Martínez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW et al..  2011.  Exemestane for breast-cancer prevention in postmenopausal women.. The New England journal of medicine. 364(25):2381-91. Abstract
Gralow JR, Burstein HJ, Wood W, Hortobagyi GN, Gianni L, von Minckwitz G, Buzdar AU, Smith IE, Symmans WF, Singh B et al..  2008.  Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(5):814-9. Abstract
L
Linden HM, Kurland BF, Peterson LM, Schubert EK, Gralow JR, Specht JM, Ellis GK, Lawton TJ, Livingston RB, Petra PH et al..  2011.  Fluoroestradiol positron emission tomography reveals differences in pharmacodynamics of aromatase inhibitors, tamoxifen, and fulvestrant in patients with metastatic breast cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(14):4799-805. Abstract
M
Mehta RS, Barlow WE, Albain KS, Vandenberg TA, Dakhil SR, Tirumali NR, Lew DL, Hayes DF, Gralow JR, Livingston RB et al..  2012.  Combination anastrozole and fulvestrant in metastatic breast cancer.. The New England journal of medicine. 367(5):435-44. Abstract